These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1337 related articles for article (PubMed ID: 33384436)

  • 1. Deposition distribution of the new coronavirus (SARS-CoV-2) in the human airways upon exposure to cough-generated droplets and aerosol particles.
    Madas BG; Füri P; Farkas Á; Nagy A; Czitrovszky A; Balásházy I; Schay GG; Horváth A
    Sci Rep; 2020 Dec; 10(1):22430. PubMed ID: 33384436
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Heterogeneity in transmissibility and shedding SARS-CoV-2 via droplets and aerosols.
    Chen PZ; Bobrovitz N; Premji Z; Koopmans M; Fisman DN; Gu FX
    Elife; 2021 Apr; 10():. PubMed ID: 33861198
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Origin and genomic characteristics of SARS-CoV-2 and its interaction with angiotensin converting enzyme type 2 receptors, focusing on the gastrointestinal tract.
    Galanopoulos M; Doukatas A; Gazouli M
    World J Gastroenterol; 2020 Nov; 26(41):6335-6345. PubMed ID: 33244196
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transmission of Severe Acute Respiratory Syndrome Coronavirus 2 via Close Contact and Respiratory Droplets Among Human Angiotensin-Converting Enzyme 2 Mice.
    Bao L; Gao H; Deng W; Lv Q; Yu H; Liu M; Yu P; Liu J; Qu Y; Gong S; Lin K; Qi F; Xu Y; Li F; Xiao C; Xue J; Song Z; Xiang Z; Wang G; Wang S; Liu X; Zhao W; Han Y; Wei Q; Qin C
    J Infect Dis; 2020 Jul; 222(4):551-555. PubMed ID: 32444876
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Why Does the SARS-CoV-2 Delta VOC Spread So Rapidly? Universal Conditions for the Rapid Spread of Respiratory Viruses, Minimum Viral Loads for Viral Aerosol Generation, Effects of Vaccination on Viral Aerosol Generation, and Viral Aerosol Clouds.
    Lee BU
    Int J Environ Res Public Health; 2021 Sep; 18(18):. PubMed ID: 34574724
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Infectious Clones Produce SARS-CoV-2 That Causes Severe Pulmonary Disease in Infected K18-Human ACE2 Mice.
    Liu X; Zaid A; Freitas JR; McMillan NA; Mahalingam S; Taylor A
    mBio; 2021 Apr; 12(2):. PubMed ID: 33879586
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Airborne transmission of SARS-CoV-2 is the dominant route of transmission: droplets and aerosols.
    Rabaan AA; Al-Ahmed SH; Al-Malkey M; Alsubki R; Ezzikouri S; Al-Hababi FH; Sah R; Al Mutair A; Alhumaid S; Al-Tawfiq JA; Al-Omari A; Al-Qaaneh AM; Al-Qahtani M; Tirupathi R; Al Hamad MA; Al-Baghli NA; Sulaiman T; Alsubait A; Mehta R; Abass E; Alawi M; Alshahrani F; Shrestha DB; Karobari MI; Pecho-Silva S; Arteaga-Livias K; Bonilla-Aldana DK; Rodriguez-Morales AJ
    Infez Med; 2021 Mar; 29(1):10-19. PubMed ID: 33664169
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Breathing Is Enough: For the Spread of Influenza Virus and SARS-CoV-2 by Breathing Only.
    Scheuch G
    J Aerosol Med Pulm Drug Deliv; 2020 Aug; 33(4):230-234. PubMed ID: 32552296
    [No Abstract]   [Full Text] [Related]  

  • 9. COVID-19: a conundrum to decipher.
    Deshmukh V; Tripathi SC; Pandey A; Deshmukh V; Vykoukal J; Patil A; Sontakke B
    Eur Rev Med Pharmacol Sci; 2020 May; 24(10):5830-5841. PubMed ID: 32495923
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Viral Load of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) in Respiratory Aerosols Emitted by Patients With Coronavirus Disease 2019 (COVID-19) While Breathing, Talking, and Singing.
    Coleman KK; Tay DJW; Tan KS; Ong SWX; Than TS; Koh MH; Chin YQ; Nasir H; Mak TM; Chu JJH; Milton DK; Chow VTK; Tambyah PA; Chen M; Tham KW
    Clin Infect Dis; 2022 May; 74(10):1722-1728. PubMed ID: 34358292
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [NPPV Treatment for Neuromuscular Diseases during the COVID-19 Pandemic].
    Fujita H; Suzuki K
    Brain Nerve; 2020 Oct; 72(10):1085-1089. PubMed ID: 33051397
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Putative mechanism of neurological damage in COVID-19 infection.
    Bandala C; Cortes-Altamirano JL; Reyes-Long S; Lara-Padilla E; Ilizaliturri-Flores I; Alfaro-Rodríguez A
    Acta Neurobiol Exp (Wars); 2021; 81(1):69-79. PubMed ID: 33949163
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dysregulation of endocytic machinery and ACE2 in small airways of smokers and COPD patients can augment their susceptibility to SARS-CoV-2 (COVID-19) infections.
    Eapen MS; Lu W; Hackett TL; Singhera GK; Thompson IE; McAlinden KD; Hardikar A; Weber HC; Haug G; Wark PAB; Chia C; Sohal SS
    Am J Physiol Lung Cell Mol Physiol; 2021 Jan; 320(1):L158-L163. PubMed ID: 33174446
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pathogenesis-directed therapy of 2019 novel coronavirus disease.
    Stratton CW; Tang YW; Lu H
    J Med Virol; 2021 Mar; 93(3):1320-1342. PubMed ID: 33073355
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oral Pathology in COVID-19 and SARS-CoV-2 Infection-Molecular Aspects.
    Drozdzik A; Drozdzik M
    Int J Mol Sci; 2022 Jan; 23(3):. PubMed ID: 35163355
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Potential pathogenesis of severe acute respiratory syndrome coronavirus 2.
    Wu T; Zhang H; Hu E; Ma J
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2020 May; 45(5):591-597. PubMed ID: 32879112
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An overview of the effect of bioaerosol size in coronavirus disease 2019 transmission.
    Guzman MI
    Int J Health Plann Manage; 2021 Mar; 36(2):257-266. PubMed ID: 33295073
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SARS-CoV-2 Infection and Significance of Oral Health Management in the Era of "the New Normal with COVID-19".
    Imai K; Tanaka H
    Int J Mol Sci; 2021 Jun; 22(12):. PubMed ID: 34207046
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Estimation of Viral Aerosol Emissions From Simulated Individuals With Asymptomatic to Moderate Coronavirus Disease 2019.
    Riediker M; Tsai DH
    JAMA Netw Open; 2020 Jul; 3(7):e2013807. PubMed ID: 32716517
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Society of swallowing and dysphagia of Japan: Position statement on dysphagia management during the COVID-19 outbreak.
    Kimura Y; Ueha R; Furukawa T; Oshima F; Fujitani J; Nakajima J; Kaneoka A; Aoyama H; Fujimoto Y; Umezaki T
    Auris Nasus Larynx; 2020 Oct; 47(5):715-726. PubMed ID: 32736887
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 67.